Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02092272 · ClinicalTrials.gov registry record · NA

Eccentric Exercises for Shoulder Pain

A NA study, sponsored by Mike O'Callaghan Military Hospital.

Terminated
Registry status
NA
Development phase
23
Enrollment target

NCT02092272: Clinical Trial NA study, sponsored by Mike O'Callaghan Military Hospital.

NCT02092272 is a NA study that was terminated before completion, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02092272, a NA study, was terminated before completion, sponsored by Mike O'Callaghan Military Hospital.

TERMINATED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

Patients will be randomly assigned to one of two groups using a random number generator. Group 1 will be provided with in-office instruction of standard of care eccentric exercises for rotator cuff tendinopathy. Group 2 will be provided with in-office instruction as well as a instructional exercise video source (DVD) to take home as a reminder on how to perform two specific standard of care eccentric exercises for rotator cuff tendinopathy. Each group will be given a card to track adherence to the standard of care eccentric exercise routine as measured only by the days that they accomplish their exercises. Study exercise diary will be collected after 12 weeks of treatment. Eccentric exercises are taught as part of standard of care for rotator cuff tendinopathy.

Interventions

  • BEHAVIORAL instructional exercise video source

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2014-03
Est. Completion 2015-02
Phase NA
Mike O'Callaghan Military Hospital

26 total trials

Why NCT02092272 stopped before completion

NCT02092272 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which instructional exercise video source is the first listed.

NCT02092272 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02092272 about?

NCT02092272 is a clinical study titled "Eccentric Exercises for Shoulder Pain". Patients will be randomly assigned to one of two groups using a random number generator. Group 1 will be provided with in-office instruction of standard of care eccentric exercises for rotator cuff tendinopathy. Group 2 will be provided with in-office instruction as well as a instructional exercise ...

What is the current status of trial NCT02092272?

This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2014-03. Estimated completion is 2015-02.

What interventions are being tested in trial NCT02092272?

The interventions under investigation include: instructional exercise video source (BEHAVIORAL).

Who is sponsoring clinical trial NCT02092272?

This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02092272's enrollment target sits among peer trials

23 1755th of 2000 higher than 245 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02092272, the US trial registry maintained by the National Library of Medicine. NCT02092272 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.